Pfizer & Glaxo Ink Multi-Million Dollar R&D Deals with Academia

[CC-Conrad Clyburn-MedForeSight]

Biotech Transfer Week reports that Pfizer and Glaxo Smith Kline (GSK) are continuing the trend toward the pharmaceutical industry funding large partnerships with academic research institutions to invigorate their innovation pipelines. The full Ben Butkus article is an excellent overview of recent initiatives by industry to leverage academic discovery.